- Investing Ideas
- /
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
21
Companies with a Value score of at least 3, ordered by Value score
21 companies
Merck
Market Cap: AR$191.3b
Operates as a healthcare company worldwide.
MRK
AR$18,200.00
7D
0.7%
1Y
-39.9%
Gilead Sciences
Market Cap: AR$134.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$33,200.00
7D
7.4%
1Y
70.5%
Bristol-Myers Squibb
Market Cap: US$95.6b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$20.50
7D
0%
1Y
n/a
Biogen
Market Cap: AR$18.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$12,225.00
7D
8.7%
1Y
-40.8%
Bristol-Myers Squibb
Market Cap: AR$95.6b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$19,000.00
7D
4.3%
1Y
16.1%
Johnson & Johnson
Market Cap: AR$366.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
AR$12,225.00
7D
3.2%
1Y
3.8%
Amgen
Market Cap: US$149.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$9.41
7D
1.2%
1Y
-8.6%
Johnson & Johnson
Market Cap: AR$369.5b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
DJNJ3
AR$1,300.00
7D
0%
1Y
0%
Bayer
Market Cap: AR$22.5b
Operates as a life science company worldwide.
BAYN
AR$3,323.26
7D
0%
1Y
n/a
Pfizer
Market Cap: AR$131.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
AR$7,000.00
7D
4.8%
1Y
-18.1%
Merck
Market Cap: US$191.3b
Operates as a healthcare company worldwide.
MRKD
US$15.45
7D
-3.1%
1Y
-45.7%
Johnson & Johnson
Market Cap: US$366.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJD
US$10.40
7D
0%
1Y
3.5%
Amgen
Market Cap: AR$149.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$11,300.00
7D
7.6%
1Y
-7.5%
Biogen
Market Cap: US$18.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$10.40
7D
9.9%
1Y
n/a
Novartis
Market Cap: US$181.7b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NVSD
US$27.60
7D
0%
1Y
16.5%
Pfizer
Market Cap: US$131.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFED
US$5.94
7D
-0.8%
1Y
-18.6%
GSK
Market Cap: US$59.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$10.10
7D
4.1%
1Y
-8.2%
Novartis
Market Cap: AR$181.7b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NVS
AR$33,475.00
7D
2.9%
1Y
10.5%
Gilead Sciences
Market Cap: US$134.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$27.15
7D
-2.9%
1Y
69.7%
GSK
Market Cap: AR$59.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$11,900.00
7D
5.8%
1Y
-11.4%
Instituto Rosenbusch
Market Cap: AR$4.5b
Manufactures and sells veterinary products in Argentina.
ROSE
AR$118.25
7D
21.9%
1Y
6.5%